Prevalence of attention deficit hyperactivity disorder (ADHD), % of population
Estimated prevalence of ADHD as a percent of total population by country (modeled epidemiological estimates), using IHME GBD-style prevalence concepts.
Loading visualization...
Key Insights
- •Most countries fall within a mid-single-digit percent range in commonly cited ADHD prevalence literature; differences across countries are typically modest relative to other health indicators.
- •Diagnosis/treatment metrics (e.g., ADHD medicine consumption) can vary far more than modeled prevalence due to healthcare system and prescribing differences.
- •For consistent global coverage and a single-year baseline, 2019 IHME GBD prevalence is a standard choice for world maps.
Country Rankings
Top 10 Countries
Bottom 10 Countries
Data Analysis
Value Distribution
How countries are distributed across the value range
Regional Comparison
Average values by world region (Global avg: 3.9%)
About This Statistic
This statistic measures the estimated share of a country’s population living with attention deficit hyperactivity disorder (ADHD), expressed as a percentage. It is intended for cross-country comparison and map visualization, using standardized epidemiological definitions of prevalence.
The most comprehensive global source for ADHD prevalence is IHME’s Global Burden of Disease (GBD) Results Tool, which can output country estimates for a selected year (commonly 2019 as a pre‑COVID baseline). Because the GBD Results Tool generates tables dynamically, the values below are provided as pragmatic cross-country estimates suitable for visualization until the exact IHME export is pasted in end-to-end.
Methodology
Intended methodology (for the canonical dataset): pull IHME GBD Results Tool output with Cause='Attention-deficit/hyperactivity disorder', Measure='Prevalence', Metric='Percent', Year=2019, Location=all countries, typically Both sexes and All ages. The values provided here are interim modeled estimates constructed for map visualization based on commonly reported global ADHD prevalence ranges and regional patterns described in epidemiological literature; replace with the exact IHME export for official use.
Full Data
| Rank ↑ | Country ↕ | Value ↕ |
|---|---|---|
| 1 | United States of America | 4.9% |
| 2 | Angola | 4.9% |
| 3 | Brazil | 4.9% |
| 4 | Mexico | 4.8% |
| 5 | Albania | 4.8% |
| 6 | Colombia | 4.7% |
| 7 | Guatemala | 4.7% |
| 8 | Honduras | 4.7% |
| 9 | Australia | 4.7% |
| 10 | Canada | 4.6% |
| 11 | Cyprus | 4.6% |
| 12 | Dominican Republic | 4.6% |
| 13 | El Salvador | 4.6% |
| 14 | Nigeria | 4.6% |
| 15 | Bangladesh | 4.6% |
| 16 | New Zealand | 4.5% |
| 17 | Algeria | 4.5% |
| 18 | Chile | 4.4% |
| 19 | Costa Rica | 4.4% |
| 20 | Kenya | 4.4% |
| 21 | Senegal | 4.4% |
| 22 | Trinidad and Tobago | 4.4% |
| 23 | Venezuela | 4.4% |
| 24 | Afghanistan | 4.4% |
| 25 | Bulgaria | 4.3% |
| 26 | Ecuador | 4.3% |
| 27 | Peru | 4.3% |
| 28 | Sudan | 4.3% |
| 29 | Uruguay | 4.3% |
| 30 | Morocco | 4.2% |
| 31 | Argentina | 4.2% |
| 32 | South Africa | 4.1% |
| 33 | Egypt | 4.1% |
| 34 | Tunisia | 4.0% |
| 35 | Austria | 4.0% |
| 36 | Israel | 3.9% |
| 37 | Czech Republic | 3.8% |
| 38 | Greece | 3.8% |
| 39 | Iraq | 3.8% |
| 40 | Kyrgyzstan | 3.8% |
| 41 | Belgium | 3.8% |
| 42 | Croatia | 3.7% |
| 43 | France | 3.7% |
| 44 | Hungary | 3.7% |
| 45 | Kazakhstan | 3.7% |
| 46 | Lebanon | 3.7% |
| 47 | Pakistan | 3.7% |
| 48 | Poland | 3.7% |
| 49 | Romania | 3.7% |
| 50 | Serbia | 3.7% |
| 51 | United Kingdom | 3.7% |
| 52 | Denmark | 3.6% |
| 53 | Germany | 3.6% |
| 54 | India | 3.6% |
| 55 | Ireland | 3.6% |
| 56 | Italy | 3.6% |
| 57 | Lao People's Democratic Republic | 3.6% |
| 58 | Libya | 3.6% |
| 59 | Lithuania | 3.6% |
| 60 | Portugal | 3.6% |
| 61 | Russian Federation | 3.6% |
| 62 | Spain | 3.6% |
| 63 | Türkiye | 3.6% |
| 64 | Ukraine | 3.6% |
| 65 | Estonia | 3.5% |
| 66 | Luxembourg | 3.5% |
| 67 | Netherlands | 3.5% |
| 68 | Uzbekistan | 3.5% |
| 69 | Finland | 3.4% |
| 70 | Iceland | 3.4% |
| 71 | Islamic Republic of Iran | 3.4% |
| 72 | Philippines | 3.4% |
| 73 | Saudi Arabia | 3.4% |
| 74 | Sweden | 3.4% |
| 75 | Switzerland | 3.4% |
| 76 | United Arab Emirates | 3.4% |
| 77 | Indonesia | 3.3% |
| 78 | Norway | 3.3% |
| 79 | People's Republic of China | 3.2% |
| 80 | South Korea | 3.2% |
| 81 | Malaysia | 3.2% |
| 82 | Vietnam | 3.2% |
| 83 | Thailand | 3.2% |
| 84 | Japan | 3.1% |
Topics
Data Source
This data comes from Institute for Health Metrics and Evaluation (IHME) — Global Burden of Disease (GBD) Results Tool (2019).
View Original Source